Presentations & Publications
Explore scientific presentations and publications about our investigational programs.
August 2024 Presentation
ACS Fall Symposium
Optimization of antagonists of toll-like receptors 7 and 8 (TLR7/8) leading to the discovery of afimetoran
June 2024 Poster
EULAR
Pharmacodynamic effects and exploratory efficacy of afimetoran, a TLR7/8 inhibitor, in patients with cutaneous lupus erythematosus
November 2023 Presentation
ACR Convergence
Safety, Tolerability, and Exploratory Efficacy of Afimetoran, a TLR7/8 Inhibitor, in Patients with Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study
November 2023 Poster
ACR Convergence
Steroid-sparing Effects of Afimetoran (BMS-986256), an Equipotent Toll-like Receptor (TLR)7 and TLR8 Antagonist, in a Lupus Mouse Model
June 2023 Poster
EULAR
Afimetoran (BMS-986256), an equipotent TLR7/8 antagonist, demonstrates steroid-sparing effects in a lupus mouse model
June 2023 Poster
EULAR
In vitro evidence demonstrates that afimetoran (BMS-986256), an equipotent TLR7/8 dual antagonist, has steroid-sparing potential in the clinic
On this page you may select links to key publications from peer-reviewed journals as well as to materials presented at scientific conferences relating to either research studies involving Beeline’s investigational product candidates or to the science guiding our research and development efforts. The safety and efficacy of any investigational product discussed in these materials has yet to be determined. Note that certain of these materials were authored by unaffiliated third parties and do not represent Beeline’s views. The content of each work is the property of the respective copyright holder and may not be further distributed without their express permission. The information in these materials may not be current or comprehensive, and Beeline undertakes no obligation to correct or update such information.
